Phreesia, Inc. (PHR) Stock Forecast

NYSE: PHRAnalyst ratings, price target and estimates.

PHR analyst forecast

as of October 18, 2026
Analyst consensus
Buy
4.00 / 5 from 18 analysts
Price target
$14.13
average of analyst targets
Upside to target
+29.2%
from the latest close
Next earnings
—
52-week range
$8.06 – $23.49

PHR analyst ratings

18 analysts
Strong buy
844%
Buy
211%
Hold
844%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

PHR price target

Price $10.94Target $14.13
52-week low $8.0652-week high $23.49

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

PHR earnings per share estimates

Phreesia, Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Oct '26)$0.37$0.28$0.47$0.31+17.2%10
Current fiscal year (FY2027)$1.28$1.12$1.68$1.29−1.0%10
Next fiscal year (FY2028)$1.61$1.44$2.00$1.28+26.1%9

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

PHR revenue estimates

Phreesia, Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Oct '26)$128.4M$125.7M$131.6M+6.7%17
Current fiscal year (FY2027)$515.8M$510.3M$520.3M+7.3%17
Next fiscal year (FY2028)$534.9M$502.7M$557.6M+3.7%16

PHR EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

PHR revenue: reported and forecast

Reported revenueEstimate (average; low–high)

PHR EPS estimate revisions

Phreesia, Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Oct '26)$0.35$0.36$0.36$0.36$0.37+3.1%1 up · 1 down
Current fiscal year (FY2027)$1.33$1.33$1.24$1.24$1.28−3.8%0 up · 1 down
Next fiscal year (FY2028)$1.61$1.61$1.61$1.61$1.61+0.4%1 up · 1 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

PHR earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; PHR beat in 10 of 12.

What analysts expect from PHR

18 analysts cover Phreesia; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $14.13, 29.2% above the latest close of $10.94. Analysts expect earnings of $1.28 per share for FY2027, −1.0% from a year earlier. For FY2028 the average estimate is $1.61 per share on revenue of $534.9 million. Phreesia beat the EPS estimate in 10 of the last 12 quarters.

Related: PHR income statement, PHR key metrics, PHR chart. See the PHR stock overview for the latest quote and news.

PHR forecast FAQ

What is Phreesia's price target?

The average analyst price target for Phreesia is $14.13, 29.2% above the latest close of $10.94.

Is Phreesia a buy, hold or sell?

Of 18 analysts covering Phreesia, 8 rate it a strong buy, 2 a buy, 8 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Phreesia's EPS forecast?

Analysts forecast $1.28 per share for FY2027 (range $1.12 to $1.68); for FY2028 the estimate is $1.61.

What is Phreesia's revenue forecast?

The average revenue estimate for FY2027 is $515.8 million, growth of 7.3%; for FY2028 it is $534.9 million.

Does Phreesia usually beat earnings estimates?

Phreesia reported EPS at or above the analyst estimate in 10 of the last 12 quarters.

Health Information Services: forecast